Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Medica Martiniana
Volume 20 (2020): Issue 2 (August 2020)
Open Access
Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
K Prso
K Prso
,
N Zidekova
N Zidekova
,
M Dohal
M Dohal
,
I Porvaznik
I Porvaznik
,
M Prso
M Prso
,
M Kertys
M Kertys
and
J Mokry
J Mokry
| Aug 20, 2020
Acta Medica Martiniana
Volume 20 (2020): Issue 2 (August 2020)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Aug 20, 2020
Page range:
45 - 55
Received:
Apr 29, 2020
Accepted:
May 28, 2020
DOI:
https://doi.org/10.2478/acm-2020-0006
Keywords
first-line antituberculosis drugs
,
therapeutic drug monitoring
,
isoniazid
,
rifampicin
,
ethambutol
,
pyrazinamide
© 2020 K Prso et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
K Prso
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
Martin, Slovakia
N Zidekova
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
Martin, Slovakia
M Dohal
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
Martin, Slovakia
I Porvaznik
Department of Clinical Microbiology, National Institute for Tuberculosis, Lung Diseases and Thoracic Surgery
Vyšné Hágy, Slovakia
Faculty of Health, Catholic University
Ružomberok, Slovakia
M Prso
Clinic of Children and Adolescents Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and Martin University Hospital
Martin
M Kertys
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
Martin, Slovakia
J Mokry
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
Martin, Slovakia